INmune Bio, Inc. (INMB)
1.46
-0.08
(-5.19%)
USD |
NASDAQ |
Oct 23, 16:00
1.49
+0.03
(+2.05%)
After-Hours: 20:00
INmune Bio Market Cap : 40.37M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 40.37M |
| October 22, 2026 | 42.59M |
| October 21, 2026 | 44.52M |
| October 20, 2026 | 44.25M |
| October 19, 2026 | 42.59M |
| October 16, 2026 | 43.42M |
| October 15, 2026 | 45.63M |
| October 14, 2026 | 44.25M |
| October 13, 2026 | 46.46M |
| October 12, 2026 | 49.22M |
| October 09, 2026 | 52.27M |
| October 08, 2026 | 50.61M |
| October 07, 2026 | 51.44M |
| October 06, 2026 | 51.71M |
| October 05, 2026 | 53.65M |
| October 02, 2026 | 53.37M |
| October 01, 2026 | 53.37M |
| September 30, 2026 | 53.92M |
| September 29, 2026 | 54.20M |
| September 28, 2026 | 55.31M |
| September 25, 2026 | 56.14M |
| September 24, 2026 | 55.31M |
| September 23, 2026 | 55.31M |
| September 22, 2026 | 59.73M |
| September 21, 2026 | 63.33M |
| Date | Value |
|---|---|
| September 18, 2026 | 64.43M |
| September 17, 2026 | 60.29M |
| September 16, 2026 | 56.69M |
| September 15, 2026 | 62.50M |
| September 14, 2026 | 64.43M |
| September 11, 2026 | 61.39M |
| September 10, 2026 | 63.88M |
| September 09, 2026 | 68.03M |
| September 08, 2026 | 69.41M |
| September 04, 2026 | 67.48M |
| September 03, 2026 | 62.77M |
| September 02, 2026 | 64.99M |
| September 01, 2026 | 61.94M |
| August 31, 2026 | 63.60M |
| August 28, 2026 | 64.43M |
| August 27, 2026 | 66.37M |
| August 26, 2026 | 67.61M |
| August 25, 2026 | 67.20M |
| August 24, 2026 | 65.26M |
| August 21, 2026 | 64.16M |
| August 20, 2026 | 59.73M |
| August 19, 2026 | 61.67M |
| August 18, 2026 | 58.35M |
| August 17, 2026 | 58.90M |
| August 14, 2026 | 60.01M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| Price to Book Value | 1.907 |
| Price | 1.46 |
| Earnings Yield | -47.42% |